We are talking about a 29 to 31 gauge needle, roughly the width of a human hair
Intravenous Immunoglobulin (IVIG) Intravenous Immunoglobulin, or IVIG, is a specialized treatment made from antibodies collected from thousands of healthy blood donors
New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year: New obesity drugs are coming, including the 'triple agonist' Retatrutide (expected for approval in 2027), which activates 3 receptors: GLP1, GIP, and glucagon In a trial, Retatrutide caused loss of ~25% of bodyweight (in patients with obesity) in less than a year: 25% in a year might be a little fast
When starting treatment, well begin with a low dose and gradually increase it over the course of 16-20 weeks
Special populations and additional considerations for alternating Not everyone faces the same risk profile when alternating medications